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mélioration significative dès les premiers jours post opératoire et reste stable à
8 mois de la chirurgie.
nfin dans les cas de fractures plus sévères ostéoporotiques, cette technique peut
tre couplée à des ostéosynthèses courtes, ce qui semble diminuer très nettement
e taux de complications et surtout le nombre de démontage du matériel.
n des problèmes liés à cette technique nous semble être le tassement secondaire
es étages adjacents, qui peut aboutir à une escalade thérapeutique qui peut être
élétère pour le patient.
oi:10.1016/j.rehab.2011.07.277
ersion anglaise
O23-001–EN
hysiopathology of spinal osteoporosis
. Chappard
Inserm 922, UFR Sciences médicales, Angers, France
o abstract provided
oi:10.1016/j.rehab.2011.07.278
O23-002–EN
rug treatment of osteoporosis
. Maugars
Service de rhumatologie, CHU Nantes, 1, place Alexis-Ricordeau, 44093
antes, France
steoporosis is responsible for more fractures in our aging population who fall.
owever, advances in treatment allow for the first time a relative decrease in the
umber of osteoporotic fractures in France. We propose a review of different
reatment options, based on the pathophysiology of bone, which may act by
timulating or inhibiting bone formation and resorption.
nhibition of bone resorption was the prerogative of bisphosphonates. The new
olecules have acquired several important features: low anti-osteoblastic to
he usual doses and powerful anti-resorptive effects, weekly or even monthly
equential administration, very long bone half-lives (short serum half-lives),
arenteral administration. Their effectiveness in prevention of osteoporotic frac-
ures is mainly vertebral (50–70%) than peripheral (15–25%). Their tolerance is
xcellent, despite new side effects highly contested (mandibular osteonecrosis,
rrhythmias, atypical fractures), and with a potential increase in life expectancy,
specially after femoral neck fracture for Zoledronate.
aloxifene is a less effective anti-resorptive drug, with a proven effect only on
ertebral fractures. It is a preventive treatment of choice in young women at risk
f postmenopausal breast cancer, without very low femoral bone density or risk
f thrombophlebitis.
eriparatide is the 1–34 fragment of PTH, stimulating bone remodeling in favor
o anabolism in sequential administration. Its anti-fracture efficacy is both spinal
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nd peripheral, following a sequence of 1.5 years subcutaneously daily injec-
ions. Its tolerance is good. It is costly and reserved for severe osteoporosis (at
east 2 vertebral fractures).
trontium ranelate is unclassifiable, a moderate anti-resorptive but also an ana-
olic effect on bone mineral. Allergic patients should be monitored closely.
inally, the future is already biotherapeutics, such as Denosumab this year, very
owerful inhibiting bone resorption by cutting communication RANK-RANK-L
etween osteoblasts and osteoclasts, well ahead of future anabolic bone treat-
ent for the Wnt pathway or specific inhibitors of collagenases of osteoclasts.
he armamentarium grows, and the announced decrease osteoporotic fractures
lready obtained, with promises of even more dramatic results in the future.
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alloon kyphoplasty is a technique developed by Reiley and Calif, in 1998,
hich involves injecting high viscosity cement after surgical reduction of ver-
ebral fracture. It is preferable to vertebroplasty when settlement is greater than
0% of vertebral body height. Injection of high viscosity cement limits leakage.
he kyphoplasty is a rapid technique (< 30 minutes per fracture level), which
llows fast loading of the patient and is associated with a low complication
ate. It allows rapid relief of pain (VAS divided by three in the first days after
urgery), and stable over time. 73% of patients regain ambulatory status in the
rst week after surgery and more than 81% at two years. The study of the SF-36
re-and postoperatively showed a significant improvement from the first days
fter surgery and remained stable at 18 months of surgery.
inally, in cases of osteoporotic fractures tougher, this technique can be coupled
ith short osteosynthesis, which seems to decrease very significantly the rate of
omplications and especially the number of dismantling the equipment.
ne problem with this technique seems to be settling secondary adjacent ver-
ebrates, which can lead to an escalation therapy may be deleterious to the
atient.
oi:10.1016/j.rehab.2011.07.281
